[go: up one dir, main page]

DE69528258D1 - Haiknorpelextrakte mit antiangiogenischer wirkung und einem effekt auf tumorregression und verfahren zur herstellung derselben - Google Patents

Haiknorpelextrakte mit antiangiogenischer wirkung und einem effekt auf tumorregression und verfahren zur herstellung derselben

Info

Publication number
DE69528258D1
DE69528258D1 DE69528258T DE69528258T DE69528258D1 DE 69528258 D1 DE69528258 D1 DE 69528258D1 DE 69528258 T DE69528258 T DE 69528258T DE 69528258 T DE69528258 T DE 69528258T DE 69528258 D1 DE69528258 D1 DE 69528258D1
Authority
DE
Germany
Prior art keywords
supernatant
vivo
tumor
extracts
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69528258T
Other languages
English (en)
Other versions
DE69528258T2 (de
Inventor
Eric Dupont
Paul Brazeau
Christina Juneau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cosciens Biopharma Inc
Original Assignee
Les Laboratories Aeterna Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratories Aeterna Inc filed Critical Les Laboratories Aeterna Inc
Application granted granted Critical
Publication of DE69528258D1 publication Critical patent/DE69528258D1/de
Publication of DE69528258T2 publication Critical patent/DE69528258T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
DE69528258T 1994-04-28 1995-04-21 Haiknorpelextrakte mit antiangiogenischer wirkung und einem effekt auf tumorregression und verfahren zur herstellung derselben Expired - Lifetime DE69528258T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23401994A 1994-04-28 1994-04-28
US08/384,555 US5618925A (en) 1994-04-28 1995-02-03 Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression; process of making thereof
PCT/CA1995/000233 WO1995032722A1 (en) 1994-04-28 1995-04-21 Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression; process of making thereof

Publications (2)

Publication Number Publication Date
DE69528258D1 true DE69528258D1 (de) 2002-10-24
DE69528258T2 DE69528258T2 (de) 2003-04-17

Family

ID=26927471

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69528258T Expired - Lifetime DE69528258T2 (de) 1994-04-28 1995-04-21 Haiknorpelextrakte mit antiangiogenischer wirkung und einem effekt auf tumorregression und verfahren zur herstellung derselben

Country Status (24)

Country Link
US (2) US5618925A (de)
EP (1) EP0759765B1 (de)
JP (1) JPH09512563A (de)
KR (1) KR100378787B1 (de)
CN (2) CN1541656A (de)
AT (1) ATE224198T1 (de)
BG (1) BG62954B1 (de)
BR (1) BR9507552A (de)
CA (1) CA2188793C (de)
CZ (1) CZ290520B6 (de)
DE (1) DE69528258T2 (de)
DK (1) DK0759765T3 (de)
ES (1) ES2182900T3 (de)
FI (1) FI117375B (de)
HU (1) HU220784B1 (de)
IS (1) IS1975B (de)
NO (1) NO317674B1 (de)
NZ (1) NZ284407A (de)
PL (1) PL181981B1 (de)
PT (1) PT759765E (de)
RO (1) RO114868B1 (de)
RU (1) RU2156132C2 (de)
SI (1) SI0759765T1 (de)
WO (1) WO1995032722A1 (de)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5618925A (en) * 1994-04-28 1997-04-08 Les Laboratories Aeterna Inc. Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression; process of making thereof
US6028118A (en) * 1996-08-08 2000-02-22 Les Laboratoires Aeterna Inc. Methods of using extracts of shark cartilage
US6380366B1 (en) * 1994-04-28 2002-04-30 Les Laboratoires Aeterna Inc. Shark cartilage extract:process of making, methods of using and compositions thereof
US6025334A (en) * 1994-04-28 2000-02-15 Les Laboratoires Aeterna Inc. Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities; process of making, methods of using and compositions thereof
RU2157695C2 (ru) * 1995-02-03 2000-10-20 Ле Лабораториз Аетерна Инк. Экстракты хрящей акулы, способ их получения и применения
US5843920A (en) * 1996-09-16 1998-12-01 Biocell Technology, Llc Anionic saccharides for extraction of anti-angiogenic protein from cartilage
CA2288269A1 (en) * 1997-02-20 1998-08-27 Industrial Research Limited Angiogenesis inhibitors and activators from shark cartilage
BR9808858A (pt) * 1997-03-11 2000-08-01 Aeterna Lab Inc Terapias antitumores compreendendo uma combinação de um extrato de cartilagem e um agente antineoplástico provendo uma alta eficácia e baixos efeitos colaterais tóxicos
EP1012163A4 (de) * 1997-07-11 2003-01-29 Cv Technologies Inc Formulierung, ausgehend von haifischknorpel, zur behandl.ung von erkrankungen, die mit erhöhtem phf oder erhöhtem intrazellulären kalzium einhergehen
US5840342A (en) * 1997-09-17 1998-11-24 Raithaus; Lawrence R. Shark liver extract for stimulating the immune system
FR2778558B1 (fr) 1998-05-12 2001-02-16 Oreal Utilisation d'inhibiteur de metalloproteinases pour induire et/ou stimuler la croissance des cheveux ou des poils et/ou freiner leur chute
PT1520588E (pt) 1998-07-13 2015-03-31 Univ Texas Usos de anticorpos para amino fosfolípidos para o tratamento do cancro
US6168807B1 (en) 1998-07-23 2001-01-02 Les Laboratoires Aeterna Inc. Low molecular weight components of shark cartilage, processes for their preparation and therapeutic uses thereof
US20020009501A1 (en) * 1998-07-23 2002-01-24 Eric Dupont Preparation of cartilage extracts using organic solvents
SI1107795T1 (en) 1998-09-04 2003-06-30 The Regents Of The University Of Michigan Thiomolybdate associated with at least one carbohydrate, and its use for preventing or treating diseases characterized by aberrant vascularization, such as cancer, wet type macular degeneration, rheumatoid arthritis
CN1064690C (zh) * 1998-09-10 2001-04-18 中国人民解放军海军医学研究所 鲨鱼软骨血管生成抑制因子及其分离纯化方法
US7361643B2 (en) 2000-02-09 2008-04-22 University Of Puerto Rico Methods for inhibiting angiogenesis
AU1649802A (en) * 2000-12-20 2002-07-01 Ind Res Ltd Shark meat extract
AUPR222300A0 (en) * 2000-12-21 2001-01-25 Life Therapeutics Limited Electrophoresis device and method
WO2002096450A1 (en) * 2001-05-30 2002-12-05 Wackvom Limited Compositions containing an active fraction isolated from ganoderma lucidum and methods of use
US20030087830A1 (en) * 2001-06-12 2003-05-08 Eric Dupont Low molecular weight components of cartilage, complexes of metals with amino acids, DI-peptides and analogs thereof; processes for preparation and therapeutic uses thereof
US6908627B2 (en) * 2001-06-21 2005-06-21 Mote Marine Laboratory Conditioned media for inhibiting growth of tumor cells
US7309501B2 (en) * 2001-06-21 2007-12-18 Mote Marine Laboratory Conditioned media to inhibit growth of tumor cells
CA2476126A1 (en) 2002-02-15 2003-08-21 Ocean Nutrition Canada Limited Shark cartilage extracts and use thereof for immunomodulation
KR20150021911A (ko) 2002-07-15 2015-03-03 더 보드 오브 리전츠 오브 더 유니버시티 오브 텍사스 시스템 포스파티딜에탄올아민에 결합하는 펩타이드, 및 바이러스 감염 및 암을 치료하는데 있어서 이의 용도
US20070010430A1 (en) * 2003-03-20 2007-01-11 Hosokawa Micron Corparation Proteoglycan isolated from cartilaginous fish and process for producing the same
US7067123B2 (en) 2003-04-29 2006-06-27 Musculoskeletal Transplant Foundation Glue for cartilage repair
US7901457B2 (en) 2003-05-16 2011-03-08 Musculoskeletal Transplant Foundation Cartilage allograft plug
ES2223291B1 (es) * 2003-08-06 2006-03-16 Bioiberica, S.A. Nuevo uso terapeutico de condroitin sulfato.
EP2335650B1 (de) 2003-12-11 2012-10-03 Isto Technologies Inc. Teilchenförmiges Knorpelsystem
CA3031283A1 (en) 2004-01-22 2005-08-04 University Of Miami Topical co-enzyme q10 formulations and methods of use
CN100377741C (zh) * 2004-02-23 2008-04-02 江卫世 注射用复方骨肽及其制备工艺
US20050288796A1 (en) * 2004-06-23 2005-12-29 Hani Awad Native soft tissue matrix for therapeutic applications
US7837740B2 (en) * 2007-01-24 2010-11-23 Musculoskeletal Transplant Foundation Two piece cancellous construct for cartilage repair
WO2006059236A2 (en) * 2004-11-16 2006-06-08 Aeterna Zentaris Inc. Method of using cartilage extract for increasing blood parameters
US7815926B2 (en) * 2005-07-11 2010-10-19 Musculoskeletal Transplant Foundation Implant for articular cartilage repair
JP5292533B2 (ja) 2005-08-26 2013-09-18 ジンマー・インコーポレイテッド インプラントおよび関節疾患の治療、置換および治療方法
WO2007035778A2 (en) 2005-09-19 2007-03-29 Histogenics Corporation Cell-support matrix and a method for preparation thereof
DE102006060247A1 (de) * 2006-09-15 2008-03-27 Ossacur Ag Differenzierung von Stammzellen
US8163549B2 (en) 2006-12-20 2012-04-24 Zimmer Orthobiologics, Inc. Method of obtaining viable small tissue particles and use for tissue repair
US8435551B2 (en) 2007-03-06 2013-05-07 Musculoskeletal Transplant Foundation Cancellous construct with support ring for repair of osteochondral defects
US20090012629A1 (en) 2007-04-12 2009-01-08 Isto Technologies, Inc. Compositions and methods for tissue repair
AU2008324045B2 (en) 2007-11-09 2014-08-07 Affitech Research As Anti-VEGF antibody compositions and methods
CA2717725A1 (en) 2008-03-05 2009-09-11 Musculoskeletal Transplant Foundation Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles
EP2262469A4 (de) * 2008-04-15 2013-12-04 Immanence Integrale Dermo Correction Inc Hautpflegezusammensetzungen und verfahren zu ihrer verwendung
AU2009274512A1 (en) 2008-07-25 2010-01-28 The Regents Of The University Of Colorado Clip inhibitors and methods of modulating immune function
US20100274362A1 (en) * 2009-01-15 2010-10-28 Avner Yayon Cartilage particle tissue mixtures optionally combined with a cancellous construct
CN101891811B (zh) * 2010-05-28 2011-11-09 暨南大学 一种鲨鱼血管生成抑制因子及其生产纯化方法和应用
CN101899104B (zh) * 2010-05-28 2012-04-18 暨南大学 一种鲨鱼软骨血管生成抑制因子小分子多肽及其生产纯化方法和应用
CN103429608B (zh) * 2011-01-19 2016-08-03 国立大学法人弘前大学 蛋白多糖的大量制备方法
US20140178343A1 (en) 2012-12-21 2014-06-26 Jian Q. Yao Supports and methods for promoting integration of cartilage tissue explants
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
CN104894200B (zh) * 2015-05-12 2020-10-30 浙江海洋学院 路氏双髻鲨软骨血管生成抑制因子的制备方法
KR101628982B1 (ko) 2015-11-27 2016-06-09 김준혁 항종양 및 면역 증강용 건강식품 조성물
WO2018145109A1 (en) 2017-02-06 2018-08-09 Massachusetts Institute Of Technology Methods and products related to glutaminase inhibitors
CN109394786A (zh) * 2018-10-26 2019-03-01 西交利物浦大学 一种抗肿瘤的药物组合物
WO2020203812A1 (ja) * 2019-03-29 2020-10-08 学校法人慶應義塾 魚介類由来成分による低酸素応答制御
US12194060B2 (en) 2019-06-14 2025-01-14 “12Life” Limited Liability Company (“I2Life” Llo) Method for the production of iodinated proteins with a determinated iodine content
CN112986499A (zh) * 2021-02-26 2021-06-18 山西奥瑞生物材料有限公司 一种同种骨植入材料残余水量均匀度测定方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3478146A (en) * 1965-02-26 1969-11-11 Leslie L Balassa Wound-healing cartilage powder extracting process
US4042457A (en) * 1975-11-10 1977-08-16 Rush-Presbyterian-St. Luke's Medical Center Preparation of tissue invasion inhibitor and method of treatment utilizing the inhibitor
US4822607A (en) * 1976-10-29 1989-04-18 Lescarden Ltd. Anti-tumor agent and method
US4243582A (en) * 1979-04-26 1981-01-06 Monsanto Company Novel glycoproteins from bovine cartilage
US4350682A (en) * 1979-05-11 1982-09-21 Lescarden Ltd. Cartilage extraction processes and products
US4356261A (en) * 1980-04-22 1982-10-26 Rush-Presbyterian-St. Luke's Medical Center Anti-invasion factor containing cultures
US4473551A (en) * 1982-08-23 1984-09-25 Faxon Pharmaceuticals, Inc. Anti-inflammatory composition
US4656137A (en) * 1985-09-12 1987-04-07 Lescarden Inc Method of processing animal cartilage
US4749522A (en) * 1985-10-31 1988-06-07 Angio-Medical Corporation Supercritical fluid extraction of animal derived materials
US4746729A (en) * 1986-07-30 1988-05-24 Kuettner Klaus E Cartilage-derived leukocyte elastase-inhibitor
US5075112A (en) * 1990-02-12 1991-12-24 Cartilage Technologies Inc. Method of and dosage unit for inhibiting angiogenesis or vascularization in an animal using shark cartilage
AU5596494A (en) * 1992-11-30 1994-06-22 I. William Lane Processing shark cartilage
DK1159974T3 (da) * 1993-07-19 2007-11-26 Angiotech Pharm Inc Antiangiogene sammensætninger indeholdende taxol og en ikke-bionedbrydelig bærer og deres anvendelse
US5618925A (en) * 1994-04-28 1997-04-08 Les Laboratories Aeterna Inc. Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression; process of making thereof

Also Published As

Publication number Publication date
BG62954B1 (bg) 2000-12-29
CZ314196A3 (en) 1997-04-16
AU719118B2 (en) 2000-05-04
NO964547L (no) 1996-12-30
CN1541656A (zh) 2004-11-03
NZ284407A (en) 1998-04-27
US5618925A (en) 1997-04-08
BR9507552A (pt) 1997-08-05
HU9602975D0 (en) 1997-01-28
KR970702729A (ko) 1997-06-10
ES2182900T3 (es) 2003-03-16
FI117375B (fi) 2006-09-29
DK0759765T3 (da) 2003-01-27
HU220784B1 (hu) 2002-05-28
IS4379A (is) 1996-10-25
CA2188793C (en) 2001-01-16
HUT76554A (en) 1997-09-29
JPH09512563A (ja) 1997-12-16
DE69528258T2 (de) 2003-04-17
EP0759765B1 (de) 2002-09-18
WO1995032722A1 (en) 1995-12-07
PL317076A1 (en) 1997-03-03
PT759765E (pt) 2003-02-28
RU2156132C2 (ru) 2000-09-20
PL181981B1 (en) 2001-10-31
KR100378787B1 (ko) 2003-06-19
NO317674B1 (no) 2004-11-29
CZ290520B6 (cs) 2002-08-14
CN1153477A (zh) 1997-07-02
RO114868B1 (ro) 1999-08-30
NO964547D0 (no) 1996-10-25
BG100941A (en) 1997-07-31
FI964327A (fi) 1996-12-20
CA2188793A1 (en) 1995-12-07
US5985839A (en) 1999-11-16
CN1147305C (zh) 2004-04-28
AU2300195A (en) 1995-12-21
SI0759765T1 (en) 2003-02-28
FI964327A0 (fi) 1996-10-28
ATE224198T1 (de) 2002-10-15
EP0759765A1 (de) 1997-03-05
IS1975B (is) 2005-01-14

Similar Documents

Publication Publication Date Title
DE69528258D1 (de) Haiknorpelextrakte mit antiangiogenischer wirkung und einem effekt auf tumorregression und verfahren zur herstellung derselben
Liu et al. Action of trypsin on structural changes of collagen fibres from sea cucumber (Stichopus japonicus)
DE69625698D1 (de) Extrakte aus haifischknorpel
DE69529300D1 (de) Haiknorpel extrakte,verfahren zur herstellung und verwendungen desselben
Wu et al. Effect of post-mortem time and temperature on bovine intramuscular collagen
Al-Ghanimi et al. Study of some functional properties of elastin extracted from bovine leather
Sumeet et al. Formation of hierarchical assemblies by collagen peptides derived from fish skin and bladder and their subsequent application as antiperoxide agents in lipid-rich food
KIRDAT STUDIES ON BIOCHEMICAL ANALYSIS OF FISH WASTE AND ITS APPLICATIONS
WO2024215349A1 (en) Method of preparing procollagen from freshwater fish
Tran et al. DETERMINATION OF MOLECULAR WEIGHT OF COLLAGEN EXTRACTED FROM BASA FISH (PANGASIUS BOCOURTI) SKIN BY DIFFERENT METHODS
GEP19960514B (en) Method for Obtaining Biologically Active Preparation "Katrex"

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: AETERNA ZENTARIS INC., QUEBEC, CA